Viewing Study NCT02468193

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:14 AM
Ignite Modification Date: 2026-02-22 @ 6:45 PM
Study NCT ID: NCT02468193
Status: COMPLETED
Last Update Posted: 2020-05-06
First Post: 2015-06-08
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cushing's Syndrome View
None Ectopic Corticotropin Syndrome View
None Adrenal Adenoma View
None Adrenal Carcinoma View
None AIMAH View
None PPNAD View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cushing's syndrome View
None osilodrostat View
None LCI699 View
None ectopic corticotropin syndrome View
None adrenal adenoma View
None adrenal carcinoma View
None ACTH-Independent Macronodular Adrenal Hyperplasia View
None AIMAH View
None Primary Pigmented Nodular Adrenal Dysplasia View
None PPNAD View